Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00414362 |
Recruitment Status
:
Completed
First Posted
: December 21, 2006
Last Update Posted
: June 26, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Urinary Tract Infection Fluoroquinolone Bacteremia |
Study Type : | Observational |
Actual Enrollment : | 1000 participants |
Observational Model: | Other |
Time Perspective: | Retrospective |
Official Title: | Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin |
Actual Study Start Date : | February 2007 |
Actual Primary Completion Date : | June 2017 |
Actual Study Completion Date : | June 2017 |

- dead or alive [ Time Frame: end of study ]health status
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
-
Clinical information is collected by chart review of "case" and "control" patients. A "case" patient is defined as follows:
- One or more blood cultures are positive for Gram-negative bacteria.
- The same organism is recovered in urine culture within a 48-hour period.
- The organism is ciprofloxacin resistant.
-
A "control" patient is defined as follows:
- One or more blood cultures are positive for Gram-negative bacteria.
- The same organism is recovered in urine culture within a 48-hour period.
- The organism is ciprofloxacin susceptible.
Exclusion Criteria:
- negative culture

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00414362
United States, Pennsylvania | |
University of Pittsburgh Medical Center | |
Pittsburgh, Pennsylvania, United States, 15213 |
Principal Investigator: | Yohei Doi, MD | University of Pittsburgh |
Responsible Party: | University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT00414362 History of Changes |
Other Study ID Numbers: |
IRB#0611103 no additional IDs |
First Posted: | December 21, 2006 Key Record Dates |
Last Update Posted: | June 26, 2017 |
Last Verified: | June 2017 |
Keywords provided by University of Pittsburgh:
Bacteremia Urinary Tract Infections Fluoroquinolone |
Additional relevant MeSH terms:
Urinary Tract Infections Bacteremia Infection Urologic Diseases Bacterial Infections Sepsis Systemic Inflammatory Response Syndrome Inflammation |
Pathologic Processes Fluoroquinolones Anti-Bacterial Agents Anti-Infective Agents Nucleic Acid Synthesis Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |